GMG
Clinical trials for GMG explained in plain language.
Never miss a new study
Get alerted when new GMG trials appear
Sign up with your email to follow new studies for GMG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to boost muscle disease treatment
Disease control Recruiting nowThis study is testing whether adding a new drug called empasiprubart to an existing treatment (efgartigimod) can better control symptoms of myasthenia gravis. It will involve about 70 adults with a specific type of this muscle-weakening disease who have had only a partial improve…
Matched conditions: GMG
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for Muscle-Weakening disease: multiple drug trials launch
Disease control Recruiting nowThis study aims to test the safety and effectiveness of several different drug combinations for people with myasthenia gravis, a condition that causes muscle weakness. It will enroll about 70 adults who have been diagnosed with the disease and are on stable treatment. The goal is…
Matched conditions: GMG
Sponsor: argenx • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for kids with rare Muscle-Weakening disease
Disease control Recruiting nowThis study is testing an investigational drug called gefurulimab in children and teenagers (ages 6 to under 18) who have generalized myasthenia gravis (gMG), a condition that causes severe muscle weakness. The main goals are to see how the drug behaves in the body, if it is safe,…
Matched conditions: GMG
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC